These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20109048)

  • 21. Current challenges in treating MRSA: what are the options?
    Ratnaraja NV; Hawkey PM
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):601-18. PubMed ID: 18847401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection.
    Pannaraj PS; Hulten KG; Gonzalez BE; Mason EO; Kaplan SL
    Clin Infect Dis; 2006 Oct; 43(8):953-60. PubMed ID: 16983604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recognizing, understanding, and treating critical community acquired methicillin-resistant Staphylococcus aureus infection in children.
    Carcillo JA; Castillo L; Thomas J; Kissoon N
    Pediatr Crit Care Med; 2009 May; 10(3):405-7. PubMed ID: 19433946
    [No Abstract]   [Full Text] [Related]  

  • 24. Antibiotic selection for MRSA: case presentations and review of the literature.
    Hanson MR; Chung CL
    J Drugs Dermatol; 2009 Mar; 8(3):281-6. PubMed ID: 19271378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Healthy children with invasive community-acquired methicillin-resistant Staphylococcus aureus infections.
    Stankovic C; Mahajan PV
    Pediatr Emerg Care; 2006 May; 22(5):361-3. PubMed ID: 16714967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antibiotic susceptibility of Staphylococcus aureus strains responsible for community-acquired skin infections].
    Bernard P; Jarlier V; Santerre-Henriksen A
    Ann Dermatol Venereol; 2008 Jan; 135(1):13-9. PubMed ID: 18342068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Community-associated methicillin-resistant Staphylococcus aureus infections among children in the western Galilee region: the beginning of an epidemic?].
    Glikman D
    Harefuah; 2009 Nov; 148(11):761-5, 794, 793. PubMed ID: 20027978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections.
    Seybold U; Kourbatova EV; Johnson JG; Halvosa SJ; Wang YF; King MD; Ray SM; Blumberg HM
    Clin Infect Dis; 2006 Mar; 42(5):647-56. PubMed ID: 16447110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Community-acquired methicillin-resistant Staphylococcus aureus infections.
    Maltezou HC; Giamarellou H
    Int J Antimicrob Agents; 2006 Feb; 27(2):87-96. PubMed ID: 16423509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology and treatment of community-associated methicillin-resistant Staphylococcus aureus in children.
    Marcinak JF; Frank AL
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):91-100. PubMed ID: 16441212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.
    Liu C; Bayer A; Cosgrove SE; Daum RS; Fridkin SK; Gorwitz RJ; Kaplan SL; Karchmer AW; Levine DP; Murray BE; J Rybak M; Talan DA; Chambers HF
    Clin Infect Dis; 2011 Feb; 52(3):285-92. PubMed ID: 21217178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of new methicillin-resistant Staphylococcus aureus clones containing the toxic shock syndrome toxin 1 gene responsible for hospital- and community-acquired infections in France.
    Durand G; Bes M; Meugnier H; Enright MC; Forey F; Liassine N; Wenger A; Kikuchi K; Lina G; Vandenesch F; Etienne J
    J Clin Microbiol; 2006 Mar; 44(3):847-53. PubMed ID: 16517865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial resistance in clinical isolates of Staphylococcus aureus from hospital and community sources in southern Jamaica.
    Brown PD; Ngeno C
    Int J Infect Dis; 2007 May; 11(3):220-5. PubMed ID: 16815064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.
    Laupland KB; Ross T; Gregson DB
    J Infect Dis; 2008 Aug; 198(3):336-43. PubMed ID: 18522502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus.
    Gonzalez BE; Martinez-Aguilar G; Hulten KG; Hammerman WA; Coss-Bu J; Avalos-Mishaan A; Mason EO; Kaplan SL
    Pediatrics; 2005 Mar; 115(3):642-8. PubMed ID: 15741366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in Latin America].
    Luna CM; Rodríguez-Noriega E; Bavestrello L; Gotuzzo E;
    Rev Chilena Infectol; 2010 Aug; 27 Suppl 2():S94-103. PubMed ID: 21137164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Community-acquired methicillin-resistant Staphylococcus aureus in Taiwan.
    Chen CJ; Huang YC
    J Microbiol Immunol Infect; 2005 Dec; 38(6):376-82. PubMed ID: 16341337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methicillin-resistant Staphylococcus aureus infections.
    Bartlett JG
    Top HIV Med; 2008 Dec; 16(5):151-5. PubMed ID: 19106430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The emergence of infections with community-associated methicillin resistant Staphylococcus aureus.
    Diederen BM; Kluytmans JA
    J Infect; 2006 Mar; 52(3):157-68. PubMed ID: 16289303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An update on community-associated MRSA virulence.
    Kobayashi SD; DeLeo FR
    Curr Opin Pharmacol; 2009 Oct; 9(5):545-51. PubMed ID: 19726228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.